- Home
- RIME vs AWH Comparison
RIME vs AWH Comparison
Compare RIME & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIME
- AWH
- Stock Information
- Founded
- RIME 1982
- AWH 1993
- Country
- RIME United States
- AWH United States
- Employees
- RIME N/A
- AWH N/A
- Industry
- RIME
- AWH Medical/Dental Instruments
- Sector
- RIME
- AWH Health Care
- Exchange
- RIME NYSE
- AWH Nasdaq
- Market Cap
- RIME 1.4M
- AWH 1.6M
- IPO Year
- RIME 1994
- AWH N/A
- Fundamental
- Price
- RIME $2.12
- AWH $0.11
- Analyst Decision
- RIME
- AWH Buy
- Analyst Count
- RIME 0
- AWH 2
- Target Price
- RIME N/A
- AWH $4.40
- AVG Volume (30 Days)
- RIME 164.6K
- AWH 13.0M
- Earning Date
- RIME 05-19-2025
- AWH 03-27-2025
- Dividend Yield
- RIME N/A
- AWH N/A
- EPS Growth
- RIME N/A
- AWH N/A
- EPS
- RIME N/A
- AWH N/A
- Revenue
- RIME $32,479,657.00
- AWH $9,182,000.00
- Revenue This Year
- RIME N/A
- AWH $11.87
- Revenue Next Year
- RIME N/A
- AWH $79.10
- P/E Ratio
- RIME N/A
- AWH N/A
- Revenue Growth
- RIME 11.81
- AWH 0.31
- 52 Week Low
- RIME $1.71
- AWH $0.08
- 52 Week High
- RIME $394.00
- AWH $3.63
- Technical
- Relative Strength Index (RSI)
- RIME N/A
- AWH 33.87
- Support Level
- RIME N/A
- AWH $0.12
- Resistance Level
- RIME N/A
- AWH $0.36
- Average True Range (ATR)
- RIME 0.00
- AWH 0.01
- MACD
- RIME 0.00
- AWH 0.01
- Stochastic Oscillator
- RIME 0.00
- AWH 37.14
About RIME ALGORHYTHM HOLDINGS INC
Algorhythm Holdings Inc is a holding company with two primary investments. It operates through its subsidiaries, one of which is an emerging leader in the AI-enabled global logistics industry. The other subsidiary is engaged in consumer karaoke products, Which designs and distributes the industry's widest assortment of at-home and in-car karaoke entertainment products.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.